Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population

Huy Quang Quach1, Inna G Ovsyannikova1, Diane E Grill2

  • 1Mayo Clinic Vaccine Research Group, Division of General of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Vaccines
|November 11, 2022
PubMed

Insights

A significant portion of vaccinated adults lack protective measles antibodies. This study highlights potential waning immunity, emphasizing the need for ongoing surveillance and potential booster strategies against measles outbreaks.

Area of Science:

  • Immunology
  • Epidemiology
  • Public Health

Background:

  • Measles control relies on high vaccine coverage and durable immunity.
  • Assessing population immunity is crucial for outbreak prevention.

Purpose of the Study:

  • To determine measles immunoglobulin G (IgG) seroprevalence in adults aged 20-44.
  • To identify factors influencing measles-specific antibody levels.

Main Methods:

  • A cohort of 1393 adults (20-44 years old) was studied.
  • Enzyme-linked immunosorbent assay (ELISA) was used to measure measles-specific IgG antibodies.

Main Results:

  • 37.6% of participants tested negative for measles IgG antibodies.
  • Sex and age significantly influenced IgG levels in the cohort.

Conclusions:

  • A substantial percentage of vaccinated adults exhibit suboptimal measles immunity.
  • This subset may be vulnerable during future measles outbreaks, necessitating further investigation.